Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

NCT02152007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Pachyonychia Congenita

Interventions

DRUG: 1% sirolimus cream (TD201 1%)

Sponsor

TransDerm, Inc.

Collaborators

[object Object]